Action Point Financial Planning’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-76
Closed -$5.79K – 1319
2026
Q2
$5.79K Buy
+76
New +$5.18K ﹤0.01% 1743

Other funds holding HALO

Action Point Financial Planning's HALO Position: Q3 2026 in Review

Action Point Financial Planning sold out of Halozyme (HALO) in Q3 2026, closing a stake of 76 shares — an estimated $5.79K sold.

Action Point Financial Planning first reported a position in HALO in Q2 2026 and held it in 1 quarter. The position peaked at $5.79K in Q2 2026. 777 funds tracked by Wall St. Rank hold HALO as of Q3 2026.

  • Action Point Financial Planning reported no remaining Halozyme position as of Q3 2026 after selling out during the quarter.
  • Action Point Financial Planning sold 76 Halozyme shares in Q3 2026, an estimated $5.79K.
  • Action Point Financial Planning first reported a position in Halozyme in Q2 2026 and held it in 1 quarter.
  • Action Point Financial Planning's Halozyme position peaked at $5.79K in Q2 2026.
  • 777 funds tracked by Wall St. Rank held Halozyme as of Q3 2026.

Based on Action Point Financial Planning's 13F filing for Q3 2026, filed 13 Nov 2026.